secwatch.observer — SEC 8-K summary
======================================

Issuer:     Petros Pharmaceuticals, Inc. (PTPI)
CIK:        0001815903
Form:       8-K
Filed at:   2025-04-09T23:59:59+00:00
Accession:  0001104659-25-033391
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Petros Pharmaceuticals terminates Marcum as auditor, engages CBIZ; prior reports include going concern
--------------------------------------------------------------------------------

- Company terminated Marcum LLP as auditor on April 5, 2025, and engaged CBIZ CPAs P.C. as new independent auditor for FY 2025.
- No disagreements or reportable events except a material weakness in internal controls over financial reporting disclosed in 2024 10-K.
- Marcum's reports for FY 2023 and 2024 included an explanatory paragraph about substantial doubt as a going concern.
- Marcum provided a letter to SEC dated April 9, 2025, agreeing with the company's statements (Exhibit 16.1 filed).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815903/000110465925033391/0001104659-25-033391-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815903/000110465925033391/tm2511732d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-033391

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer